Cargando…

Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors

Several recent cardiovascular trials of SGLT 2 (sodium-glucose cotransporter 2) inhibitors revealed that they could reduce adverse cardiovascular events in patients with T2DM (type 2 diabetes mellitus). However, the exact molecular mechanism underlying the beneficial effects that SGLT2 inhibitors ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabravolski, Siarhei A., Zhuravlev, Alexander D., Kartuesov, Andrey G., Borisov, Evgeny E., Sukhorukov, Vasily N., Orekhov, Alexander N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140946/ https://www.ncbi.nlm.nih.gov/pubmed/35628174 http://dx.doi.org/10.3390/ijms23105371

Ejemplares similares

Interplay between Zn(2+) Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Oligosaccharides as Potential Therapeutics against Atherosclerosis
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Effect of Glucose Levels on Cardiovascular Risk
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Role of the mtDNA Mutations and Mitophagy in Inflammaging
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Atherosclerosis in HIV Patients: What Do We Know so Far?
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Editorial: Lipids and Inflammation in Health and Disease
por: Bezsonov, Evgeny, et al.
Publicado: (2022)

Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
por: Blagov, Alexander V., et al.
Publicado: (2022)

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

The Role of Mitochondria in Cardiovascular Diseases
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
por: Kłos, Patrycja, et al.
Publicado: (2021)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing
por: Khotina, Victoria A., et al.
Publicado: (2023)

Harms and benefits of sodium-glucose co-transporter 2 inhibitors
por: Chesterman, Thomas, et al.
Publicado: (2020)

Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
por: Neumiller, Joshua J, et al.
Publicado: (2022)

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
por: Armour, Sarah L., et al.
Publicado: (2022)

Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
por: Blagov, Alexander V., et al.
Publicado: (2022)

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
por: Blagov, Alexander V., et al.
Publicado: (2023)

Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control
por: Baruah, Manash Pratim, et al.
Publicado: (2019)

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
por: Lopaschuk, Gary D., et al.
Publicado: (2020)

Evolution of the Membrane Transport Protein Domain
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Impaired Mitochondrial Function in T-Lymphocytes as a Result of Exposure to HIV and ART
por: Blagov, Alexander V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ltq2n9d9vn8c7fbteaampivt5p